# Tom Goodrich

> Tom Goodrich is a Co-Founder and General Partner at Corner Ventures, a Palo Alto-based venture capital firm spun out of DAG Ventures in 2018. With more than three decades of investing and private equity experience, Goodrich leads Corner's biotech investment portfolio - including notable exits like Armo Biosciences (acquired by Eli Lilly) and Arresto Biosciences (acquired by Gilead Sciences). Before Corner Ventures, he co-founded DAG Ventures in 2004 and Duff Ackerman & Goodrich in 1991, and earlier in his career worked at Bechtel Investments, served as a consultant to Bank of America's chairman, and helped build Dimensional Corporate Finance with backing from Xerox. He holds an A.B. from Dartmouth College and an MBA from Stanford Graduate School of Business.

- **Role:** Co-Founder and General Partner at Corner Ventures
- **Organizations:** Corner Ventures, DAG Ventures, Duff Ackerman & Goodrich, Dimensional Corporate Finance, Inc., Bechtel Investments
- **Nationality:** American
- **Education:** A.B., Dartmouth College, MBA, Stanford Graduate School of Business
- **Known for:** Co-founded three investment firms spanning private equity and venture capital over 35+ years, Led Corner Ventures' biotech investments including Armo Biosciences (acquired by Eli Lilly), Arresto Biosciences (acquired by Gilead Sciences), and Atara Biotherapeutics (NASDAQ: ATRA), Helped build DAG Ventures into a $300M fund that backed nearly 180 startups including Yelp, Wix, Wealthfront, Eventbrite, Grubhub, Nextdoor, Glassdoor, Fireeye, and Ambarella

## Career timeline

- **early career** — Consultant with Stanford Research Institute
- **early career** — Independent consultant to the office of the Chairman of Bank of America
- **early career** — Co-Founder and Vice President of Dimensional Corporate Finance, Inc. (Xerox-backed specialty finance firm)
- **early career** — Principal at Bechtel Investments, overseeing management buyouts and special situation investments in mid-size growth companies
- **1991** — Co-Founded Duff Ackerman & Goodrich, a private investment firm, alongside David Duff and Ron Ackerman
- **2004** — Co-Founded DAG Ventures with John Cadeddu, spun off from Duff Ackerman & Goodrich; grew to $300M fund, backed ~180 startups
- **2018** — Co-Founded Corner Ventures with John Cadeddu and Marvin Tien, spun off from DAG Ventures; headquartered in Palo Alto with offices in New York, Tel Aviv, and Tokyo

## Achievements

- Co-founded three investment firms spanning private equity and venture capital over 35+ years
- Led Corner Ventures' biotech investments including Armo Biosciences (acquired by Eli Lilly), Arresto Biosciences (acquired by Gilead Sciences), and Atara Biotherapeutics (NASDAQ: ATRA)
- Helped build DAG Ventures into a $300M fund that backed nearly 180 startups including Yelp, Wix, Wealthfront, Eventbrite, Grubhub, Nextdoor, Glassdoor, Fireeye, and Ambarella
- Corner Ventures portfolio boasts 4 unicorns, 8 IPOs, and 40 acquisitions
- Built an investment network spanning the US, Israel, and Japan
- Backed Metacafe ($35M rounds) and Stoke ($93M across multiple rounds) while at DAG Ventures

## Latest updates

- **2025-12** — Corner Ventures invested in Quantum Art (Series A, December 2025)
- **2025-07** — Corner Ventures invested in Receive (Seed funding, July 2025)

## Links

- Website: https://www.cornerventures.com/
- LinkedIn: http://www.linkedin.com/in/tom-goodrich-267903332

---

Profile page: https://yespress.io/tom-goodrich
Published by YesPress — https://yespress.io
Last updated: 2026-05-17